Patients aged 40 years and younger saw longer interval times between melanoma incidences vs. patients aged 50 to 59 years and 80 years or older.
Of Interest
Enhanced melanoma vaccine offers improved survival for men (IMAGE)
Craig L. Slingluff Jr., MD, and his team at UVA Cancer Center have developed a second-generation melanoma vaccine to treat the dangerous skin cancer.
AI Accurately Predicts Skin Cancer Risk Based on 2D Facial Images
An artificial intelligence (AI) mode was more accurate in assessing patient risks for skin cancer through the analysis of 2D facial images compared with more traditional risk-factor screening.
Skin Cancer Overdiagnosis in White Americans Is Increasing, Study Says
An ecological study revealed increasing rates of skin cancer overdiagnosis in white Americans.